We quantitatively detected the anticancer effect of DDP/VP-16, mRNA and protein expression of ERCC1/TOP2A in C57BL/6 mice with tumor and in human NSCLC A549 cells, as well as in RNAi A549 cells. Here, TOP2A is linked to neoplasm.